{"id":813439,"date":"2025-02-14T09:10:52","date_gmt":"2025-02-14T14:10:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/"},"modified":"2025-02-14T09:10:52","modified_gmt":"2025-02-14T14:10:52","slug":"longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/","title":{"rendered":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MIAMI, Feb.  14, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vIJHg-rf52DsN261-hbhJ62zoF8bK5a4GBRQaUTnC-uc-jPJ19JYWDSerKFr8POXdqTozK9NG--t3Z5SOXY1Fw==\" rel=\"nofollow\" target=\"_blank\">Longeveron Inc.<\/a> (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025.<\/p>\n<p align=\"justify\">Details for the Company\u2019s presentation:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">Date:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">February 19, 2025<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">Time:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">3:10 \u2013 3:20 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">The webcast for this conference presentation may be accessed at the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z7EdmKqIUUgW6NoJ0y4goY_qe2wovJIFrVjGfaiMJuBbNaBJwxxM4G_ztv6JodahR7K-2qQzcSBytWl-ZhpN2lUHxBDQaHnxOzKK3DEnWqGLtIaouhjL_HVSTayLJLejLq1I0fGxHmHL8TsL_IBzPMjj7SrrgB8A6D9eSnH_2cs=\" rel=\"nofollow\" target=\"_blank\">Events and Presentations<\/a>\u201d section of the Company\u2019s website. A replay of the webcast will be available on the Longeveron website for 180 days following the conference.<\/p>\n<p align=\"justify\">Questions may be submitted in advance to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZPX9nIdE9r5hhuZP3UPkQI8jPAp6TGy2ObFM6_1trD9tXH2dDtXB3UP5P6wYebOhMmKYe9bNeA9p1YIB9BbuvbDmMWP0TaxFTJbxsr1mL1-QPzppzsqY5rSumKeV9gvL\" rel=\"nofollow\" target=\"_blank\">Questions@EmergingGrowth.com<\/a> or asked during the event.<\/p>\n<p>\n        <strong>About Longeveron Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company\u2019s lead investigational product is Lomecel-B\u2122, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B\u2122 has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer\u2019s disease, and Aging-related Frailty. Lomecel-B<sup>TM<\/sup> development programs have received five distinct and important FDA designations: for the HLHS program &#8211; Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program &#8211; Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vOpizphDW2dA2oZKqbZohDeDETI2LWo-A-lGvnzZym1CqJ9-vqWurSHd5gxpGjlWHqlgn0prrmRNu5NDE1kCa6e6p4Lceb-lWalMH00sdSs=\" rel=\"nofollow\" target=\"_blank\">www.longeveron.com<\/a> or follow Longeveron on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f8AcXsCAdwjVURhFLbVH27F0EcmiybAAq8485LjEX3BnE7Rq2qQaVS1x4LCQpQWMkEsVwT7EOyHssafPA0vk3nLhVzmHWFTlVPEOqpJModI=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=STYOGQFZAZ9oXO7o4xKfnwuGhEe0rglntxcZ24AVqST8z50QPbflgPHShdoJOpUiLFOjhTDw9hRGatijJJyx4Q==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=avYRwCh2pZpgvmm0KQWOAznKMawTCK2BvdmaRZDfHdhFxP9kpk3wzWv8Ovupifjcgzc39-gY6coy_udFDvgHeILS4aRbYupHAkcTWIRhsW8=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contact:<\/strong><br \/>\n        <br \/>Derek Cole<br \/>Investor Relations Advisory Solutions<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yeBo9HO3K9Lu8TsNZHK4b9nymweWQp4XRzGQYMUoSQMVp1TIj0jBVsGiAWBwdvYw0e9iAY2MBAM62eqJ2HO1XitBySsnca8rKt3LTBqQWEl52sDuj9cDoPA4jztKbiqE\" rel=\"nofollow\" target=\"_blank\">derek.cole@iradvisory.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmQ1OTQyNDEtM2ZkOS00ODVhLTg4MWMtMmQ1MjY5ZmQ4OGE1LTEyMTg2MTM=\/tiny\/Longeveron.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) &#8212; Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025. Details for the Company\u2019s presentation: \u00a0 \u00a0 Date: February 19, 2025 Time: 3:10 \u2013 3:20 p.m. ET \u00a0 \u00a0 The webcast for this conference presentation may be accessed at the \u201cEvents and Presentations\u201d section of the Company\u2019s website. A replay of the webcast will be available on the Longeveron website for 180 days following the conference. Questions may be submitted in advance to Questions@EmergingGrowth.com or asked during the event. About Longeveron Inc. Longeveron is a clinical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-813439","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) &#8212; Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025. Details for the Company\u2019s presentation: \u00a0 \u00a0 Date: February 19, 2025 Time: 3:10 \u2013 3:20 p.m. ET \u00a0 \u00a0 The webcast for this conference presentation may be accessed at the \u201cEvents and Presentations\u201d section of the Company\u2019s website. A replay of the webcast will be available on the Longeveron website for 180 days following the conference. Questions may be submitted in advance to Questions@EmergingGrowth.com or asked during the event. About Longeveron Inc. Longeveron is a clinical &hellip; Continue reading &quot;Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-14T14:10:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025\",\"datePublished\":\"2025-02-14T14:10:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/\",\"name\":\"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\",\"datePublished\":\"2025-02-14T14:10:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/","og_locale":"en_US","og_type":"article","og_title":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk","og_description":"MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) &#8212; Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025. Details for the Company\u2019s presentation: \u00a0 \u00a0 Date: February 19, 2025 Time: 3:10 \u2013 3:20 p.m. ET \u00a0 \u00a0 The webcast for this conference presentation may be accessed at the \u201cEvents and Presentations\u201d section of the Company\u2019s website. A replay of the webcast will be available on the Longeveron website for 180 days following the conference. Questions may be submitted in advance to Questions@EmergingGrowth.com or asked during the event. About Longeveron Inc. Longeveron is a clinical &hellip; Continue reading \"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-14T14:10:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025","datePublished":"2025-02-14T14:10:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/","name":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=","datePublished":"2025-02-14T14:10:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1ODM4OCM2NzUxMDIyIzIyMDcwNjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longeveron-to-present-at-the-emerging-growth-virtual-conference-on-february-19-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=813439"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813439\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=813439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=813439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=813439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}